Targeting mTOR in the Context of Diet and Whole-body Metabolism.
Ontology highlight
ABSTRACT: The mechanistic target of the rapamycin (mTOR) signaling pathway is the central regulator of cell growth and proliferation by integrating growth factor and nutrient availability. Under healthy physiological conditions, this process is tightly coordinated and essential to maintain whole-body homeostasis. Not surprisingly, dysregulated mTOR signaling underpins several diseases with increasing incidence worldwide, including obesity, diabetes, and cancer. Consequently, there is significant clinical interest in developing therapeutic strategies that effectively target this pathway. The transition of mTOR inhibitors from the bench to bedside, however, has largely been marked with challenges and shortcomings, such as the development of therapy resistance and adverse side effects in patients. In t
SUBMITTER: Koundouros N
PROVIDER: S-EPMC9391686 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA